CompletedPhase 4NCT00380770

HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT

Studying Kaposi sarcoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of KwaZulu
Principal Investigator
Anisa Mosam, FC Derm,PhD
Nelson R Mandela School of Medicine, University of Kwazulu Natal
Intervention
Generic HAART Triomune : d4T, 3TC, NVP(drug)
Enrollment
112 enrolled
Eligibility
18 years · All sexes
Timeline
20032009

Study locations (1)

Collaborators

AIDS Care Research in Africa · National Research Foundation, Singapore · AIDS Malignancy Consortium · Cipla Medpro · Dermatological Society of South Africa

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00380770 on ClinicalTrials.gov

Other trials for Kaposi sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Kaposi sarcoma

← Back to all trials